Skip to main content
SpringerLink
Log in

Ischämie des vorderen Kreislaufs

  • Chapter
NeuroIntensiv

  • 3763 Accesses

Zusammenfassung

Die Erstuntersuchung von Patienten mit akutem Schlaganfall sollte sich auf folgende Bereiche konzentrieren:

  • Vitalfunktionen,

  • neurologische Symptome, Schwere der neurologischen Funktionsstörungen auf der Basis validierter Schlaganfallskalen,

  • Erhebung des Zeitpunkt des Symptombeginns, potenzielle Eignung für spezifi sche Behandlungen,

  • laborchemische Parameter wie Elektrolyte, Blutzucker, Blutbild und Gerinnungsparameter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Zu 27.1–Zu 27.3

  1. The National Institute of Neurological Disorders and Stroke rtPA Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587

    Article  Google Scholar 

  2. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T (1999) Eects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 340:1781–1787

    Article  PubMed  CAS  Google Scholar 

  3. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329

    Article  PubMed  CAS  Google Scholar 

  4. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G (2010) Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ecass, atlantis, ninds, and epithet trials. Lancet 375:1695–1703

    Article  PubMed  CAS  Google Scholar 

  5. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G (2007) Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (sits-most): An observational study. Lancet 369:275–282

    Article  PubMed  CAS  Google Scholar 

  6. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, Erila T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kohrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G (2008) Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe implementation of thrombolysis in stroke-monitoring study (sits-most). Stroke 39:3316–3322

    Article  PubMed  Google Scholar 

  7. The National Institute of Neurological Disorders Stroke rtPA Stroke Study Group (2005) Recombinant Tissue Plasminogen Activator for Minor Strokes: The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Experience. Ann Emerg Med 46:243–252

    Article  Google Scholar 

  8. Baumann CR, Baumgartner RW, Gandjour J, von Buedingen CH, Siegel AM, Georgiadis D (2006) Good Outcomes in Ischemic Stroke Patients Who Receive Intravenous Tissue Plasminogen Activator Despite Significant Improvement of Symptoms. Stroke 37:1332–1333

    Article  PubMed  Google Scholar 

  9. Tanne D, Gorman MJ, Bates VE, Kasner SE, Scott P, Verro P, Binder JR, Dayno JM, Schultz LR, Levine SR (2000) Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience. Stroke 31:370–375

    Article  PubMed  CAS  Google Scholar 

  10. Patel SC, Levine SR, Tilley BC, Grotta JC, Lu M, Frankel M, Haley ECJ, Brott TG, Broderick JP, Horowitz S, Lyden PD, Lewandowski CA, Marler JR, Welch KMA, for the National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group (2001) Lack of clinical significance of early ischemic changes on computed tomography in acute ischemic stroke. JAMA 286:2830–2838

    Article  PubMed  CAS  Google Scholar 

  11. Mishra NK, Diener HC, Lyden PD, Bluhmki E, Lees KR (2010) Influence of age on outcome from thrombolysis in acute stroke. A controlled comparison in patients from the virtual international stroke trials archive (vista). Stroke 41:2840–2848

    Article  PubMed  Google Scholar 

  12. Schellinger PD, Jansen O, ebach JB, Pohlers O, Ryssel H, Heiland S, Steiner T, Hacke W, Sartor K (2000) Feasibility and practicality of mr imaging of stroke in the managment of hyperacute cerebral ischemia. American Journal of Neuroradiology 21:1184–1189

    PubMed  CAS  Google Scholar 

  13. Thomalla G, Ringleb P, Köhrmann M, Schellinger PD (2009) Patientenauswahl zur Thrombolyse mittels Perfusions- und Diusions-MRT. Aktuelle Datenlage. Nervenarzt 80:119–129

    Article  PubMed  CAS  Google Scholar 

  14. Schellinger PD, Thomalla G, ehler J, Köhrmann M, Molina CA, Neumann-Haefelin T, Ribo M, Singer OC, Zaro-Weber O, Sobesky J (2007) MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 38:2640–2645

    Article  PubMed  Google Scholar 

  15. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP (2006) Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 60:508–517

    Article  PubMed  Google Scholar 

  16. Kakuda W, Lansberg MG, Thijs VN, Kemp SM, Bammer R, Wechsler LR, Moseley ME, Marks MP, Albers GW (2008) Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab 28:887–891

    Article  PubMed  Google Scholar 

  17. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, nk JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM (2008) Eects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 7:299–309

    Article  PubMed  Google Scholar 

  18. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, ebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA, Schneider D, Schwamm LH, Leal JS, Söhngen M, Teal PA, Wilhelm-Ogunbiyi K, Wintermark M, Warach S (2009) Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 8:141–150

    Article  PubMed  CAS  Google Scholar 

  19. Mishra NK, Albers GW, Davis SM, Donnan GA, Furlan AJ, Hacke W, Lees KR (2010) Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 41:e25–33

    Article  PubMed  Google Scholar 

  20. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F, for the PROACT Investigators (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA 282:2003–2011

    Article  PubMed  CAS  Google Scholar 

  21. Arnold M, Schroth G, Nedeltchev K, Loher T, Remonda L, Stepper F, Sturzenegger M, Mattle HP (2002) Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 33:1828–1833

    Article  PubMed  Google Scholar 

  22. Rha JH, Saver JL (2007) The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38:967–973

    Article  PubMed  Google Scholar 

  23. Tomsick TA, Khatri P, Jovin T, Demaerschalk B, Malisch T, Demchuk A, Hill MD, Jauch E, Spilker J, Broderick JP (2010) Equipoise among recanalization strategies. Neurology 74:1069–1076

    Article  PubMed  CAS  Google Scholar 

  24. Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, Demchuk AM, Martin R, Mauldin P, Dillon C, Ryckborst KJ, Janis S, Tomsick TA, Broderick JP (2008) Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 3:130–137

    Article  PubMed  Google Scholar 

  25. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T (1999) Combined intravenous and intraarterial r-TPA versus intraarterial therapy of acute ischemic stroke: Emerging Management of Stroke (EMS) Bridging Trial. Stroke 30:2598–2605

    Article  PubMed  CAS  Google Scholar 

  26. IMS Study Investigators (2004) Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35:904–911

    Article  Google Scholar 

  27. IMS II Trial Investigators (2000) The Interventional M anagement of Stroke (IMS) II Study. Stroke 2007;38:2127–35.Ernst R, Pancioli A, Tomsick T, Kissela B, Woo D, Kantner D, Jauch E, Carrozzella J, Spilker J, Broderick J. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 31:2552–2557

    Article  Google Scholar 

  28. Daertshofer M, Gass A, Ringleb P, Sitzer M, Sliwka U, Els T, Sedlaczek O, Koroshetz WJ, Hennerici MG (2005) Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia: Increased Risk of Hemorrhage With Combined Ultrasound and Tissue Plasminogen Activator. Results of a Phase II Clinical Trial. Stroke 36:1441–1446

    Article  Google Scholar 

  29. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez- Sabin J, Montaner J, Saqqur M, Demchuk AM, Moyé LA, Hill MD, Wojner AW; CLOTBUST Investigators (2004) Ultrasoundenhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 351:2170–2178

    Article  PubMed  CAS  Google Scholar 

  30. Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, Arenillas JF, Huertas R, Purroy F, Delgado P, Alvarez-Sabin J (2006) Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 37:425–429

    Article  PubMed  CAS  Google Scholar 

  31. Molina CA, Barreto AD, Tsivgoulis G, Sierzenski P, MalkoMD, Rubiera M, Gonzales N, Mikulik R, Pate G, Ostrem J, Singleton W, Manvelian G, Unger EC, Grotta JC, Schellinger PD, Alexandrov AV (2009) Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol 66:28–38

    Article  PubMed  CAS  Google Scholar 

  32. Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators (2005) Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke 36:880–890

    Article  CAS  Google Scholar 

  33. Adams HP Jr., Effron MB, Torner J, Davalos A, Frayne J, Teal P, Leclerc J, Oemar B, Padgett L, Barnathan ES, Hacke W (2008) Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial. Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 39:87–99

    Article  PubMed  CAS  Google Scholar 

  34. Seitz RJ, Hamzavi M, Junghans U, Ringleb PA, Schranz C, Siebler M (2003) Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke. Preliminary observations. Stroke 34:1932–1935

    Article  PubMed  Google Scholar 

  35. Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, Borenstein P, Andersson B, Perez J, Caparo C, Ilic S, Oron U (2007) Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Eectiveness and Safety Trial-1 (NEST- 1). Stroke 38:1843–1849

    Article  PubMed  Google Scholar 

  36. Zivin JA, Albers GW, Bornstein N, Chippendale T, Dahlof B, Devlin T, Fisher M, Hacke W, Holt W, Ilic S, Kasner S, Lew R, Nash M, Perez J, Rymer M, Schellinger P, Schneider D, Schwab S, Veltkamp R, Walker M, Streeter J (2009) Eectiveness and Safety of Transcranial Laser Therapy for Acute Ischemic Stroke. Stroke 40:1359–1364

    Article  PubMed  Google Scholar 

  37. Georgiadis D, Schwarz S, Baumgartner RW, Veltkamp R, Schwab S (2001) Influence of positive end-expiratory pressure on intracranial pressure and cerebral perfusion pressure in patients with acute stroke. Stroke 32:2088–2092

    Article  PubMed  CAS  Google Scholar 

  38. Davalos A, Ricart W, Gonzalez-Huix F, Soler S, Marrugat J, Molins A, Suner R, Genis D (1996) Eect of malnutrition after acute stroke on clinical outcome. Stroke 27:1028–1032

    Article  PubMed  CAS  Google Scholar 

  39. Gariballa SE, Parker SG, Taub N, Castleden CM (1998) Influence of nutritional status on clinical outcome after acute stroke. Am J Clin Nutr 68:275–281

    PubMed  CAS  Google Scholar 

  40. Bardutzky J, Georgiadis D, Kollmar R, Schwab S (2004) Energy expenditure in ischemic stroke patients treated with moderate hypothermia. Intensive Care Med 30:151–154

    Article  PubMed  Google Scholar 

  41. Adams HP Jr., del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38:1655–1711

    Article  PubMed  Google Scholar 

  42. ESO Writing Committee (2008) Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 25:457–507

    Article  Google Scholar 

  43. Van Aken H, Puchstein C, Anger C, Lawin P (1983) The influence of urapidil, a new antihypertensive agent, on cerebral perfusion pressure in dogs with and without intracranial hypertension. Intensive Care Med 9:123–126

    Article  PubMed  Google Scholar 

  44. Tateishi A, Sano T, Takeshita H, Suzuki T, Tokuno H (1988) Eects of nifedipine on intracranial pressure in neurosurgical patients with arterial hypertension. J Neurosurg 69:213–215

    Article  PubMed  CAS  Google Scholar 

  45. Ahmed N, Näsman P, Wahlgren NG (2000) Eect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 31:1250–1255

    Article  PubMed  CAS  Google Scholar 

  46. Patel RV, Ramadan NM, Levine SR, Welch KM, Fagan SC (1996) Effects of ramipril and enalapril on cerebral blood flow in elderly patients with asymptomatic carotid artery occlusive disease. J Cardiovasc Pharmacol 28:48–52

    Article  PubMed  CAS  Google Scholar 

  47. Kobayashi S, Yamaguchi S, Okada K, Suyama N, Bokura K, Murao M (1992) The eect of enalapril maleate on cerebral blood flow in chronic cerebral infarction. Angiology 43:378–388

    Article  PubMed  CAS  Google Scholar 

  48. Lisk DR, Grotta JC, Lamki LM, Tran HD, Taylor JW, Molony DA, Barron BJ (1993) Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 50:855–862

    Article  PubMed  CAS  Google Scholar 

  49. Rordorf G, Koroshetz WJ, Ezzeddine MA, Segal AZ, Buonanno FS (2001) A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 56:1210–1213

    PubMed  CAS  Google Scholar 

  50. Schwarz S, Georgiadis D, Ascho A, Schwab S (2002) Eects of induced hypertension on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke 33:998–1004

    Article  PubMed  Google Scholar 

  51. Marzan AS, Hungerbuhler HJ, Studer A, Baumgartner RW, Georgiadis D (2004) Feasibility and safety of norepinephrineinduced arterial hypertension in acute ischemic stroke. Neurology 62:1193

    PubMed  CAS  Google Scholar 

  52. Bardutzky J, Schwab S (2007) Antiedema therapy in ischemic stroke. Stroke 38:3084–3094

    Article  PubMed  CAS  Google Scholar 

  53. Schwarz S, Georgiadis D, Ascho A, Schwab S (2002) Eects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke 33:497–501

    Article  PubMed  Google Scholar 

  54. Manno EM, Adams RE, Derdeyn CP, Powers WJ, Diringer MN (1999) The eects of mannitol on cerebral edema after large hemispheric cerebral infarct. Neurology 52:583–587

    PubMed  CAS  Google Scholar 

  55. Bereczki D, Fekete I, Prado GF, Liu M (2007) Mannitol for acute stroke. Cochrane Database Syst Rev 2007:CD001153

    Google Scholar 

  56. Bereczki D, Mihalka L, Szatmari S, Fekete K, Di Cesar D, Fulesdi B, Csiba L, Fekete I (2003) Mannitol use in acute stroke: case fatality at 30 days and 1 year. Stroke 34:1730–1735

    Article  PubMed  CAS  Google Scholar 

  57. Steiner T, Pilz J, Schellinger P, Wirtz R, Friederichs V, Ascho A, Hacke W (2001) Multimodal online monitoring in middle cerebral artery territory stroke. Stroke 32:2500–2506

    Article  PubMed  CAS  Google Scholar 

  58. Meyer JS, Itoh Y, Okamoto S, Welch KM, Mathew NT, Ott EO, Sakaki S, Miyakawa Y, Chabi E, Ericsson AD (1975) Circulatory and metabolic eects of glycerol infusion in patients with recent cerebral infarction. Circulation 51:701–712

    PubMed  CAS  Google Scholar 

  59. Sakamaki M, Igarashi H, Nishiyama Y, Hagiwara H, Ando J, Chishiki T, Curran BC, Katayama Y (2003) Eect of glycerol on ischemic cerebral edema assessed by magnetic resonance imaging. J Neurol Sci 209:69–74

    Article  PubMed  CAS  Google Scholar 

  60. Righetti E, Celani MG, Cantisani T, Sterzi R, Boysen G, Ricci S (2004) Glycerol for acute stroke. Cochrane Database Syst Rev 2004(2):CD000096

    Google Scholar 

  61. Schwarz S, Schwab S, Bertram M, et al. (1998) Eects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 29: 1550–1555

    Article  PubMed  CAS  Google Scholar 

  62. Qureshi AI, Suarez JI, Bhardwaj A, et al. (1998) Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Eect on intracranial pressure and lateral displacement of the brain. Crit Care Med 26: 440–446

    Article  PubMed  CAS  Google Scholar 

  63. Schwarz S, Georgiadis D, Ascho A, Schwab S: Eects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002;33(1):136–140.

    Article  PubMed  CAS  Google Scholar 

  64. Gaab MR, Seegers K, Smedema RJ, Heissler HE, Goetz C (1990) A comparative analysis of THAM (Tris-buer) in traumatic brain oedema. Acta Neurochir Suppl (Wien) 51:320–323

    CAS  Google Scholar 

  65. Wolf AL, Levi L, Marmarou A, Ward JD, Muizelaar PJ, Choi S, Young H, Rigamonti D, Robinson WL (1993) Eect of THAM upon outcome in severe head injury: a randomized prospective clinical trial. J Neurosurg 78:54–59

    Article  PubMed  CAS  Google Scholar 

  66. Jensen K, Ohrstrom J, Cold GE, Astrup J (1991) The eects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochir (Wien) 108;116–121

    Article  CAS  Google Scholar 

  67. Biestro AA, Alberti RA, Soca AE, Cancela M, Puppo CB, Borovich B (1995) Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: preliminary report. J Neurosurg 83:627–630

    Article  PubMed  CAS  Google Scholar 

  68. Schwab S, Spranger M, Schwarz S, Hacke W (1997) Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology 48:1608–1613

    PubMed  CAS  Google Scholar 

  69. Qizilbash N, Lewington SL, Lopez-Arrieta JM (2002) Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Re. 2002:CD000064

    Google Scholar 

  70. Michenfelder JD, Milde JH (1977) Failure of prolonged hypocapnia, hypothermia, or hypertension to favorably alter acute stroke in primates. Stroke 8:87–91

    Article  PubMed  CAS  Google Scholar 

  71. Muizelaar JP, Marmarou A, Ward JD, Kontos HA, Choi SC, Becker DP, Gruemer H, Young HF (1991) Adverse eects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg 75:731–739

    Article  PubMed  CAS  Google Scholar 

  72. Gupta R, Connolly ES, Mayer S, Elkind MS (2004) Hemicraniectomy for massive middle cerebral artery territory infarction: A systematic review. Stroke 35:539–543

    Article  PubMed  Google Scholar 

  73. Vahedi K, Hofmeijer J, Jüttler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, Van Der Worp HB, Hacke W; DECIMAL, DESTINY, and HAMLET investigators (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6:215–222

    Article  PubMed  Google Scholar 

  74. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W (1998) Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 29:2461–2466

    Article  PubMed  CAS  Google Scholar 

  75. Schwab S, Georgiadis D, Berrouschot J, Schellinger PD, Graffangino C, Mayer SA (2001) Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 32:2033–2035

    Article  PubMed  CAS  Google Scholar 

  76. Krieger DW, De Georgia MA, Abou-Chebl A, Andrefsky JC, Sila CA, Katzan IL, Mayberg MR, Furlan AJ (2001) Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke 32:1847–1854

    Article  PubMed  CAS  Google Scholar 

  77. Steiner T, Friede T, Ascho A, Schellinger PD, Schwab S, Hacke W (2001) Eect and feasibility of controlled rewarming after moderate hypothermia in stroke patients with malignant infarction of the middle cerebral artery. Stroke 32:2833–2835

    Article  PubMed  CAS  Google Scholar 

  78. Georgiadis D, Schwarz S, Kollmar R, Schwab S (2001) Endovascular cooling for moderate hypothermia in patients with acute stroke: first results of a novel approach. Stroke 32:2550–2553

    Article  PubMed  CAS  Google Scholar 

  79. Guluma KZ, Hemmen TM, Olsen SE, Rapp KS, Lyden PD (2006) A trial of therapeutic hypothermia via endovascular approach in awake patients with acute ischemic stroke: Methodology. Acad Emerg Med 13:820–827

    Article  PubMed  Google Scholar 

  80. Georgiadis D, Schwarz S, Ascho A, Schwab S (2002) Hemicraniectomy and moderate hypothermia in patients with severe hemispheric stroke. Stroke 33:1584–1588

    Article  PubMed  CAS  Google Scholar 

Zu 27.4

  1. Debette S, Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol 2009; 8(7):668–678

    Article  PubMed  Google Scholar 

  2. Lee VH, Brown RD Jr., Mandrekar JN, Mokri B. Incidence and outcome of cervical artery dissection: a population-based study. Neurology 2006; 67(10):1809–1812

    Article  PubMed  Google Scholar 

  3. Leys D, Bandu L, Henon H, Lucas C, Mounier-Vehier F, Rondepierre P, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology 2002; 59(1):26–33

    PubMed  CAS  Google Scholar 

  4. Baumgartner RW, Arnold M, Baumgartner I, Mosso M, Gonner F, Studer A, et al. Carotid dissection with and without ischemic events: local symptoms and cerebral artery findings. Neurology 2001; 57(5):827–832

    PubMed  CAS  Google Scholar 

  5. Fiebach J, Brandt T, Knauth M, Jansen O. MRI with fat suppression in the visualization of wall hematoma in spontaneous dissection of the internal carotid artery. Rofo 1999; 171(4):290–293

    Article  PubMed  CAS  Google Scholar 

  6. Benninger DH, Georgiadis D, Gandjour J, Baumgartner RW. Accuracy of color duplex ultrasound diagnosis of spontaneous carotid dissection causing ischemia. Stroke 2006; 37(2):377–381

    Article  PubMed  Google Scholar 

  7. Georgiadis D, Lanczik O, Schwab S, Engelter S, Sztajzel R, Arnold M, et al. IV thrombolysis in patients with acute stroke due to spontaneous carotid dissection. Neurology 2005; 64(9):1612–1614

    Article  PubMed  CAS  Google Scholar 

  8. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25(5):457–507

    Google Scholar 

  9. Georgiadis D, Arnold M, von Buedingen HC, Valko P, Sarikaya H, Rousson V, et al. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients. Neurology 2009; 72(21):1810–1815

    Article  PubMed  CAS  Google Scholar 

  10. Slovut DP, Olin JW. bromuscular dysplasia. N Engl J Med 2004; 350(18):1862–1871

    Article  PubMed  CAS  Google Scholar 

  11. Lassiter FD. The string-of-beads sign. Radiology 1998; 206(2):437–438

    PubMed  CAS  Google Scholar 

  12. Olin JW, Pierce M. Contemporary management of fibromuscular dysplasia. Curr Opin Cardiol 2008; 23(6):527–536

    Article  PubMed  Google Scholar 

  13. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20(3):288–299

    Article  PubMed  CAS  Google Scholar 

  14. Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke 2008; 39(12):3193–3200

    Article  PubMed  Google Scholar 

  15. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997; 99 (Suppl 2):S238–240

    PubMed  Google Scholar 

  16. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993; 3(3):256–259

    Article  PubMed  CAS  Google Scholar 

  17. Razvi SS, Davidson R, Bone I, Muir KW. The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry 2005; 76(5):739–741

    Article  PubMed  CAS  Google Scholar 

  18. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995; 346(8980):934–939

    Article  PubMed  CAS  Google Scholar 

  19. Rolfs A, Bottcher T, Zschiesche M, Morris P, Winchester B, Bauer P, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005; 366(9499):1794–1796

    Article  PubMed  Google Scholar 

  20. Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry disease. JAMA 2000; 284(21):2771–2775

    Article  PubMed  CAS  Google Scholar 

  21. MacLaren K, Gillespie J, Shrestha S, Neary D, Ballardie FW. Primary angiitis of the central nervous system: emerging variants. QJM 2005; 98(9):643–654

    Article  PubMed  CAS  Google Scholar 

  22. Demaerel P, De Ruyter N, Maes F, Velghe B, Wilms G. Magnetic resonance angiography in suspected cerebral vasculitis. Eur Radiol 2004; 14:1005–1012

    Article  PubMed  Google Scholar 

  23. Alrawi A, Trobe JD, Blaivas M, Musch DC. Brain biopsy in primary angiitis of the central nervous system. Neurology 1999; 53(4):858–860

    PubMed  CAS  Google Scholar 

  24. Moore PM. Diagnosis and management of isolated angiitis of the central nervous system. Neurology 1989; 39:67–173

    Google Scholar 

  25. Siva A. Vasculitis of the nervous system. J Neurology 2001; 248:451–468

    Article  CAS  Google Scholar 

  26. Jacobi C, Lenhard T, Meyding-Lamadé U. Vaskulitis des Nervensystems bei Infektionserkrankungen. Nervenarzt 2010; 81:172–180

    Article  PubMed  CAS  Google Scholar 

  27. Wutzler P, Doerr HW. Antivirale Therapie des Zoster. Dtsch Ärzteblatt 1998; 95:95–99

    Google Scholar 

  28. Balfour HH Jr. Antiviral drugs. N Engl J Med 1999; 340:1255–1268

    Article  PubMed  CAS  Google Scholar 

  29. Belizna CC, Hamidou MA, Levesque H, Guillevin L, Shoenfeld Y. Infection and vasculitis. Rheumatology 2009; 48:475–482

    Article  PubMed  Google Scholar 

  30. Thwaites GE, Tran TH. Tuberculous meningitis: many qustions, too few answers. Lancet Neurol 2005; 4:160–170

    PubMed  Google Scholar 

  31. Pfister HW, Borasio GD. Cerebrovscular complications of becterial meningitis in adults. Neurology 1992; 42:1497–1504

    PubMed  CAS  Google Scholar 

  32. May EF, Jabbari B. Stroke in neuroborreliosis. Stroke 1990; 21:1232–1235

    Article  PubMed  CAS  Google Scholar 

  33. Chahine LM, Khoitary RN, Tomfard WJ, Hussain MS. The changing face of neurosyphilis. Int J Stroke 2011; 6(2):136–143

    Article  PubMed  Google Scholar 

  34. Younger DS. Vasculitis of the nervous system. Curr Opin Neurol 2004; 17:317–336

    Article  PubMed  Google Scholar 

  35. Cantú C, Barinagarrementeria F. Cerebrovas cular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch Neurol 1996; 53:233–239

    Article  PubMed  Google Scholar 

  36. Helbok R, Brenneis C, Engelhardt K, Beer R, Lackner P, Brössner G, Pfausler B, Schmutzhard E. A rare case of Toxocara canis cerebral vasculitis. Eur J Neurol 2007; 14:e49

    Article  PubMed  CAS  Google Scholar 

  37. Pittella JE, Lana-Peixoto MA. Brain involve ment in hepatosplenic Schistosomiasis mansoni. Brain 1981; 104:621–632

    Article  PubMed  CAS  Google Scholar 

  38. Sneddon IB. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 1965; 77:777–782

    Article  Google Scholar 

  39. Robollo M, Val JF, Ganjo F, Quintano F, Berciano J. Livedo reticularis and cerebrovascular lesions (Sneddon´s syndrome) clinical, radiological and pathological features in eight cases. Brain 1986; 106:965–979

    Article  Google Scholar 

  40. Hamedani AG, Cole JW, Mitchell BD, Kittner SJ. Meta-Analysis of Factor V Leiden and Ischemic Stroke in Young Adults. The Importance of Case Ascertainment. Stroke 2010; 41:1599–1603

    Article  PubMed  Google Scholar 

  41. Bushnell CD, Goldstein LB. Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke. Stroke 2000; 31:3067–3078

    Article  PubMed  CAS  Google Scholar 

  42. Morris JG, Singh S, Fisher M. Testing for Inherited Thrombophilias in Arterial Stroke: Can It Cause More Harm Than Good? Stroke 2010; 41:2985–2990

    Article  PubMed  Google Scholar 

  43. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible ce rebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007; 130:3091–3101

    Article  PubMed  Google Scholar 

  44. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstric tion syndromes. Ann Intern Med 2007; 146:34–44

    PubMed  Google Scholar 

  45. Snygg-Martin U, Gustafsson L, Rosengren L, Alsiö A, Ackerholm P, Andersson R, Olaison L. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis 2008; 47(1):23–30

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik, Friedrich-Alexander- Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen

    Prof. Dr. Stefan Schwab

  2. Benediktuskrankenhaus, Neurologische Klinik und Geriatrie Johannes Wesling Klinikum Minden, Hans-Nolte-Str. 1, 32429, Minden

    Prof. Dr. Peter Schellinger

  3. Klinik für Anästhesiologie, Klinikum der Johannes Gutenberg-Universität Mainz, Langenbeckstr. 1, 55131, Mainz

    Prof. Dr. Christian Werner

  4. Neurochirurgische Klinik, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg

    Prof. Dr. Andreas Unterberg & Prof. Dr. Dr. Werner Hacke

Authors
  1. Prof. Dr. Stefan Schwab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Peter Schellinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. Christian Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prof. Dr. Andreas Unterberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Prof. Dr. Dr. Werner Hacke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen

    Stefan Schwab

  2. Benediktuskrankenhaus, Neurologische Klinik und Geriatrie Johannes Wesling Klinikum Minden, Hans-Nolte-Str. 1, 32429, Minden

    Peter Schellinger

  3. Klinik für Anästhesiologie, Klinikum der Johannes Gutenberg-Universität Mainz, Langenbeckstr. 1, 55131, Mainz

    Christian Werner

  4. Neurochirurgische Klinik, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg

    Andreas Unterberg  & Werner Hacke  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schwab, S., Schellinger, P., Werner, C., Unterberg, A., Hacke, W. (2012). Ischämie des vorderen Kreislaufs. In: Schwab, S., Schellinger, P., Werner, C., Unterberg, A., Hacke, W. (eds) NeuroIntensiv. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16911-3_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-16911-3_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-16910-6

  • Online ISBN: 978-3-642-16911-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation